Novartis Oncology Organizational Development Manager Salaries in Santa Barbara, CA
The average Novartis Oncology Organizational Development Manager in Santa Barbara, CA earns an estimated $126,409 annually, which includes an estimated base salary of $108,961 with a $17,448 bonus. Novartis Oncology's Organizational Development Manager compensation is $24,185 more than the US average for a Organizational Development Manager. Organizational Development Manager salaries at Novartis Oncology in Santa Barbara, CA can range from $50,000 - $292,000.
In Santa Barbara, CA, The HR Department at Novartis Oncology earns $442 more on average than the Operations Department.
Last updated 3 years ago.
- $108,961
- avg. base
- $17,448
- avg. bonus
Organizational Development Manager Salaries at Novartis Oncology
In Santa Barbara, CA, Organizational Development Managers earn $4,344 more than HR Managers, and $56,811 less than Directors of HR.
Compensation at Novartis Oncology by Department
In Santa Barbara, CA, The HR Department averages $442 more than the Operations Department, and $3,334 less than the Design Department
Organizational Development Manager Compensation by Gender (All Companies)
The average female Organizational Development Manager at companies similar size to Novartis Oncology reported making $116,859, while the average male Organizational Development Manager at similar sized companies reported making $136,237.
Organizational Development Manager Compensation by Ethnicity (All Companies)
The average Native American Organizational Development Manager at companies similar size to Novartis Oncology reported making $160,000, while the average Caucasian Organizational Development Manager at similar sized companies reported making $114,466.
How Organizational Development Managers at Novartis Oncology Rate Their Compensation
The majority of Organizational Development Managers at Novartis Oncology believe they're not compensated fairly. 100% of Organizational Development Managers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
